Pluri entered strategic collaborations across Asia, Europe and the United States ('U.S.”) to transform food and agriculture production via its subsidiaries’ advanced cell expansion ...

Oncopeptides AB ( ($SE:ONCO) ) has shared an update. Oncopeptides AB announced a change in the number of votes due to the conversion of class C ...

Korean biosimilar specialist Celltrion has penned a deal worth more than $740 million biobucks for two preclinical autoimmune ...

PROPOSED LISTING OF CELL C HOLDINGS LIMITED ON THE MAIN BOARD OF THE JSE LIMITED AND ABRIDGED PRE-LISTING STATEMENT THE ABRIDGED PRE-LISTING STATEMENT DOES NOT CONSTITUTE AN OFFER TO ANY PERSON IN ANY ...

Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Hello, and thank you for standing by. Welcome to Allogene ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

Priority Research Communication by Professor Yogesh Dwivedi and colleagues at the University of Alabama at Birmingham reports original, peer-reviewed findings demonstrating that long noncoding RNAs ...

Occupying part of the historic Crewe Works site, the expanded facilities opened on October 28 include three new heating, ...

Celltrion will develop and commercialize Kaigene's nonclinical-stage antibody assets, KG006 and KG002, under an exclusive licensing agreement. -- Kaigene will receive $8M upfront payment and up to ...

Acetylation of lysine residues in the tail domain of histone H3 is well characterized, but lysine residues in the histone globular domain are also acetylated. Histone modifications in globular domain ...

On November 9th, FOTON Motor held its 2026 Global Partners Conference in Beijing, themed "DRIVE TO GREAT". Over 2,000 dealers, key clients, partners, and media representatives from more than 140 ...

Kaigene Inc. has entered into an exclusive global licensing agreement with Celltrion Inc. for two of Kaigene's nonclinical-stage assets, KG006 and KG002.